WVE WAVE Life Sciences | 10/2/2026 | Reiterated Rating | $3.88 | | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 8/18/2026 | Boost Price Target | $33.16 | $55.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 8/10/2026 | Reiterated Rating | $131.10 | | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 8/3/2026 | Reiterated Rating | $5.51 | | Buy | $0.00 00.00% ROI | |
MDGL Madrigal Pharmaceuticals | 7/31/2026 | Reiterated Rating | $493.11 | | Buy | $0.00 00.00% ROI | |
BIIB Biogen | 7/30/2026 | Boost Price Target | $205.31 | $251.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 7/24/2026 | Set Price Target | $88.44 | $36.00 | | $0.00 00.00% ROI | |
LQDA Liquidia | 7/23/2026 | Boost Price Target | $89.25 | $130.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 7/22/2026 | Reiterated Rating | $143.94 | $270.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 7/20/2026 | Reiterated Rating | $108.32 | $220.00 | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
MTVA MetaVia | 7/10/2026 | Reiterated Rating | $1.73 | | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 6/30/2026 | Reiterated Rating | $9.86 | $32.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 6/11/2026 | Reiterated Rating | $5.66 | | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 6/8/2026 | Reiterated Rating | $13.32 | $34.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 6/5/2026 | Boost Price Target | $62.32 | $75.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 6/5/2026 | Set Price Target | $63.95 | $28.00 | | $0.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 6/2/2026 | Downgrade | $6.42 | $3.00 | Neutral | $0.00 00.00% ROI | |
CPRX Catalyst Pharmaceuticals | 5/28/2026 | Downgrade | $31.32 | $31.50 | Neutral | $0.00 00.00% ROI | |
TARA Protara Therapeutics | 5/20/2026 | Reiterated Rating | $4.34 | | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 5/19/2026 | Lower Price Target | $6.40 | $13.00 | Buy | $0.00 00.00% ROI | |
MTVA MetaVia | 5/18/2026 | Reiterated Rating | $1.11 | $20.00 | Buy | $0.00 00.00% ROI | |
BIIB Biogen | 5/14/2026 | Reiterated Rating | $195.04 | | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 5/12/2026 | Boost Price Target | $53.30 | $67.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 5/8/2026 | Reiterated Rating | $101.30 | | Buy | $0.00 00.00% ROI | |
MDGL Madrigal Pharmaceuticals | 5/6/2026 | Reiterated Rating | $502.47 | $620.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 5/1/2026 | Downgrade | $26.66 | $27.00 | Neutral | $0.00 00.00% ROI | |
AURA Aura Biosciences | 4/29/2026 | Boost Price Target | $6.96 | $24.00 | Buy | $0.00 00.00% ROI | |
TARA Protara Therapeutics | 4/29/2026 | Boost Price Target | $5.06 | $27.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 4/14/2026 | Lower Price Target | $7.26 | $18.00 | Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 4/7/2026 | Boost Price Target | $132.48 | $215.00 | Buy | $0.00 00.00% ROI | |
BIIB Biogen | 4/2/2026 | Boost Price Target | $183.78 | $237.00 | Buy | $0.00 00.00% ROI | |
UTHR United Therapeutics | 3/31/2026 | Boost Price Target | $583.78 | $660.00 | Buy | $0.00 00.00% ROI | |
MTVA MetaVia | 3/27/2026 | Lower Price Target | $1.27 | $20.00 | Buy | $0.00 00.00% ROI | |
DNLI Denali Therapeutics | 3/26/2026 | Boost Price Target | $22.47 | $42.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 3/26/2026 | Boost Price Target | $149.18 | $245.00 | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 3/25/2026 | Reiterated Rating | $13.66 | $34.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 3/24/2026 | Boost Price Target | $115.73 | $270.00 | Buy | $0.00 00.00% ROI | |
SVRA Savara | 3/16/2026 | Reiterated Rating | $5.22 | | Buy | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 3/10/2026 | Boost Price Target | $460.87 | $641.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 3/6/2026 | Boost Price Target | $34.52 | $55.00 | Buy | $0.00 00.00% ROI | |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
AMLX Amylyx Pharmaceuticals | 3/4/2026 | Boost Price Target | $14.67 | $34.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 3/2/2026 | Reiterated Rating | $13.93 | $30.00 | Buy | $0.00 00.00% ROI | |
UTHR United Therapeutics | 2/26/2026 | Boost Price Target | $503.28 | $600.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 2/24/2026 | Boost Price Target | $117.90 | $255.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 2/23/2026 | Reiterated Rating | $164.91 | $230.00 | Buy | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/17/2026 | Set Price Target | $491.47 | $591.00 | | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/13/2026 | Boost Price Target | $465.02 | $518.00 | Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/12/2026 | Lower Price Target | $137.44 | $192.00 | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 2/10/2026 | Boost Price Target | $14.22 | $28.00 | Buy | $0.00 00.00% ROI | |
BIIB Biogen | 2/9/2026 | Boost Price Target | $201.18 | $228.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 1/9/2026 | Boost Price Target | $15.82 | $37.00 | Buy | $0.00 00.00% ROI | |
MTVA MetaVia | 1/6/2026 | Boost Price Target | $8.21 | $40.00 | Buy | $0.00 00.00% ROI | |
SVRA Savara | 12/23/2025 | Boost Price Target | $6.47 | $10.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 12/19/2025 | Boost Price Target | $15.84 | $30.00 | Buy | $0.00 00.00% ROI | |
INSM Insmed | 12/18/2025 | Lower Price Target | $165.88 | $230.00 | Buy | $0.00 00.00% ROI | |
DBVT DBV Technologies | 12/18/2025 | Set Price Target | $20.80 | $40.00 | | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 12/17/2025 | Boost Price Target | $148.74 | $198.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 12/15/2025 | Set Price Target | $91.07 | $200.00 | Buy | $0.00 00.00% ROI | |
DBVT DBV Technologies | 12/15/2025 | Reiterated Rating | $18.37 | $35.00 | Buy | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 12/15/2025 | Boost Price Target | $7.58 | $32.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 12/11/2025 | Boost Price Target | $97.90 | $190.00 | Buy | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 12/9/2025 | Boost Price Target | $94.30 | $134.00 | Buy | $0.00 00.00% ROI | |
KMDA Kamada | 12/9/2025 | Boost Price Target | $6.73 | $13.00 | Buy | $0.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 12/8/2025 | Boost Price Target | $8.90 | $25.00 | Buy | $0.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 11/24/2025 | Boost Price Target | $11.29 | $18.00 | Buy | $0.00 00.00% ROI | |
MDGL Madrigal Pharmaceuticals | 11/21/2025 | Boost Price Target | $556.75 | $620.00 | Buy | $0.00 00.00% ROI | |
ARCT Arcturus Therapeutics | 11/11/2025 | Lower Price Target | $8.69 | $9.00 | Neutral | $0.00 00.00% ROI | |
MDGL Madrigal Pharmaceuticals | 11/11/2025 | Boost Price Target | $524.24 | $568.00 | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 11/7/2025 | Boost Price Target | $12.36 | $20.00 | Buy | $0.00 00.00% ROI | |
PRTA Prothena | 11/7/2025 | Boost Price Target | $10.19 | $30.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 11/6/2025 | Boost Price Target | $75.75 | $190.00 | Buy | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 11/5/2025 | Boost Price Target | $59.91 | $84.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 11/4/2025 | Boost Price Target | $27.25 | $50.00 | Buy | $0.00 00.00% ROI | |
UTHR United Therapeutics | 10/30/2025 | Boost Price Target | $450.79 | $525.00 | Buy | $0.00 00.00% ROI | |
DBVT DBV Technologies | 10/29/2025 | Reiterated Rating | $14.55 | $20.00 | Buy | $0.00 00.00% ROI | |
ARCT Arcturus Therapeutics | 10/24/2025 | Reiterated Rating | $12.00 | $12.00 | Neutral | $0.00 00.00% ROI | |
ALEC Alector | 10/22/2025 | Lower Price Target | $1.52 | $5.00 | Buy | $0.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 10/20/2025 | Reiterated Rating | $8.99 | $12.00 | Buy | $0.00 00.00% ROI | |
AKRO Akero Therapeutics | 10/10/2025 | Reiterated Rating | $54.08 | $54.00 | Neutral | $0.00 00.00% ROI | |
AKRO Akero Therapeutics | 10/10/2025 | Downgrade | $53.88 | $54.00 | Neutral | $0.00 00.00% ROI | |
PRTA Prothena | 10/7/2025 | Boost Price Target | $9.86 | $20.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 10/6/2025 | Reiterated Rating | $22.43 | $35.00 | Buy | $00.00 00.00% ROI | |
ETNB 89BIO | 9/19/2025 | Downgrade | $14.96 | $14.50 | Neutral | $0.00 00.00% ROI | |
KYMR Kymera Therapeutics | 9/18/2025 | Boost Price Target | $48.12 | $70.00 | Buy | $000.00 00.00% ROI | |
UTHR United Therapeutics | 9/5/2025 | Boost Price Target | $380.47 | $500.00 | Buy | $000.00 00.00% ROI | |
TERN Terns Pharmaceuticals | 9/4/2025 | Initiated Coverage | $7.44 | $7.44 | Neutral | $0.00 00.00% ROI | |
MTVA MetaVia | 9/4/2025 | Initiated Coverage | $7.36 | $132.00 | Buy | $0.00 00.00% ROI | |
MDGL Madrigal Pharmaceuticals | 9/4/2025 | Initiated Coverage | $435.27 | $500.00 | Buy | $000.00 00.00% ROI | |
ARCT Arcturus Therapeutics | 9/4/2025 | Initiated Coverage | $17.19 | $60.00 | Buy | $00.00 00.00% ROI | |
AKRO Akero Therapeutics | 9/4/2025 | Initiated Coverage | $45.62 | $72.00 | Buy | $0.00 00.00% ROI | |
Buffett's Final Warning: "The Dollar Is Going to Hell" (Ad) On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell."
Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral."
But there's a specific asset class and investment system that actually thrives when the dollar collapses. Watch how to protect yourself from what Dalio and Buffett see coming (free training). |
ETNB 89BIO | 9/4/2025 | Initiated Coverage | $9.24 | $32.00 | Buy | $0.00 00.00% ROI | |
SVRA Savara | 9/3/2025 | Boost Price Target | $3.39 | $8.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 9/3/2025 | Reiterated Rating | $7.55 | $22.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 8/15/2025 | Boost Price Target | $46.10 | $75.00 | Buy | $000.00 00.00% ROI | |
SVRA Savara | 8/15/2025 | Upgrade | $3.01 | $5.00 | Buy | $0.00 00.00% ROI | |
ARVN Arvinas | 8/7/2025 | Lower Price Target | $6.11 | $18.00 | Buy | $0.00 00.00% ROI | |
DAWN Day One Biopharmaceuticals | 8/6/2025 | Lower Price Target | $6.88 | $25.00 | Buy | $0.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 8/5/2025 | Lower Price Target | $472.27 | $478.00 | Buy | $000.00 00.00% ROI | |
PRTA Prothena | 8/5/2025 | Reiterated Rating | $6.94 | $14.00 | Buy | $0.00 00.00% ROI | |
BIIB Biogen | 8/1/2025 | Boost Price Target | $128.00 | $194.00 | Buy | $000.00 00.00% ROI | |
UTHR United Therapeutics | 7/31/2025 | Set Price Target | $281.95 | $400.00 | Buy | $000.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 7/29/2025 | Upgrade | $7.65 | $12.00 | Buy | $0.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 7/8/2025 | Boost Price Target | $15.06 | $27.00 | Buy | $00.00 00.00% ROI | |
CADL Candel Therapeutics | 6/30/2025 | Upgrade | $4.90 | $23.00 | Buy | $00.00 00.00% ROI | |
KYMR Kymera Therapeutics | 6/26/2025 | Reiterated Rating | $46.47 | $60.00 | Buy | $000.00 00.00% ROI | |
BIIB Biogen | 6/26/2025 | Reiterated Rating | $127.31 | $187.00 | Buy | $000.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 6/26/2025 | Reiterated Rating | $22.50 | $32.00 | Buy | $00.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 6/23/2025 | Reiterated Rating | $440.87 | $550.00 | Buy | $000.00 00.00% ROI | |
INSM Insmed | 6/11/2025 | Boost Price Target | $90.93 | $120.00 | Buy | $00.00 00.00% ROI | |
ARVN Arvinas | 6/2/2025 | Set Price Target | $7.51 | $24.00 | | $0.00 00.00% ROI | |
SVRA Savara | 5/29/2025 | Downgrade | $2.14 | $2.00 | Neutral | $0.00 00.00% ROI | |
PEPG PepGen | 5/29/2025 | Lower Price Target | $1.58 | $8.00 | Buy | $0.00 00.00% ROI | |
LQDA Liquidia | 5/28/2025 | Boost Price Target | $15.60 | $35.00 | Buy | $00.00 00.00% ROI | |
PRTA Prothena | 5/27/2025 | Lower Price Target | $6.58 | $14.00 | Buy | $00.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 5/19/2025 | Boost Price Target | $22.26 | $32.00 | Buy | $00.00 00.00% ROI | |
FHTX Foghorn Therapeutics | 5/14/2025 | Upgrade | $4.21 | | Strong-Buy | $0.00 00.00% ROI | |
ANNX Annexon | 5/14/2025 | Lower Price Target | $1.75 | $14.00 | Buy | $0.00 00.00% ROI | |
STOK Stoke Therapeutics | 5/14/2025 | Lower Price Target | $8.90 | $35.00 | Buy | $00.00 00.00% ROI | |
INSM Insmed | 5/12/2025 | Reiterated Rating | $65.08 | $90.00 | Buy | $000.00 00.00% ROI | |
LQDA Liquidia | 5/12/2025 | Reiterated Rating | $15.32 | $29.00 | Buy | $00.00 00.00% ROI | |
DYN Dyne Therapeutics | 5/9/2025 | Lower Price Target | $11.32 | $38.00 | Buy | $00.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 5/9/2025 | Boost Price Target | $4.65 | $16.00 | Buy | $00.00 00.00% ROI | |
PEPG PepGen | 5/9/2025 | Lower Price Target | $1.58 | $14.00 | Buy | $0.00 00.00% ROI | |
PRTA Prothena | 5/9/2025 | Lower Price Target | $7.43 | $30.00 | Buy | $00.00 00.00% ROI | |
ALEC Alector | 5/9/2025 | Boost Price Target | $1.11 | $10.00 | Buy | $0.00 00.00% ROI | |
KROS Keros Therapeutics | 5/8/2025 | Lower Price Target | $13.68 | $25.00 | Buy | $00.00 00.00% ROI | |
DNLI Denali Therapeutics | 5/7/2025 | Lower Price Target | $13.55 | $32.00 | Buy | $00.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 5/6/2025 | Reiterated Rating | $11.03 | $30.00 | Buy | $0.00 00.00% ROI | |
UTHR United Therapeutics | 5/5/2025 | Reiterated Rating | $294.60 | $425.00 | Buy | $000.00 00.00% ROI | |
DBVT DBV Technologies | 5/5/2025 | Boost Price Target | $8.95 | $16.00 | Buy | $00.00 00.00% ROI | |
BIIB Biogen | 5/2/2025 | Lower Price Target | $121.39 | $187.00 | Buy | $000.00 00.00% ROI | |
ARVN Arvinas | 5/2/2025 | Lower Price Target | $7.08 | $24.00 | Buy | $00.00 00.00% ROI | |
ACIU AC Immune | 5/1/2025 | Lower Price Target | $1.73 | $12.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 4/30/2025 | Reiterated Rating | $23.44 | $38.00 | Buy | $000.00 00.00% ROI | |
STRO Sutro Biopharma | 4/29/2025 | Reiterated Rating | $8.97 | $20.00 | Neutral | $00.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 4/22/2025 | Lower Price Target | $100.68 | $168.00 | Buy | $000.00 00.00% ROI | |
INSM Insmed | 4/22/2025 | Reiterated Rating | $69.51 | $90.00 | Buy | $000.00 00.00% ROI | |
ARVN Arvinas | 4/7/2025 | Reiterated Rating | $6.56 | $81.00 | Buy | $00.00 00.00% ROI | |
IMAB I-Mab | 4/4/2025 | Lower Price Target | $0.73 | $7.00 | Buy | $0.00 00.00% ROI | |
ACIU AC Immune | 4/3/2025 | Reiterated Rating | $1.88 | $16.00 | Buy | $0.00 00.00% ROI | |
My top 3 AI picks for the next decade (Ad) Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005.
Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade. Click here to get all three AI stock names from Alexander Green |
PVLA Palvella Therapeutics | 4/1/2025 | Reiterated Rating | $27.99 | $38.00 | Buy | $000.00 00.00% ROI | |
KROS Keros Therapeutics | 4/1/2025 | Reiterated Rating | $10.19 | $40.00 | Buy | $00.00 00.00% ROI | |
SVRA Savara | 3/28/2025 | Reiterated Rating | $2.78 | $6.00 | Buy | $0.00 00.00% ROI | |
ABOS Acumen Pharmaceuticals | 3/28/2025 | Lower Price Target | $1.23 | $11.00 | Buy | $0.00 00.00% ROI | |
ZNTL Zentalis Pharmaceuticals | 3/27/2025 | Reiterated Rating | $1.76 | $10.00 | Buy | $0.00 00.00% ROI | |
WVE WAVE Life Sciences | 3/26/2025 | Reiterated Rating | $9.75 | $22.00 | Buy | $00.00 00.00% ROI | |
LQDA Liquidia | 3/20/2025 | Reiterated Rating | $14.92 | $29.00 | Buy | $00.00 00.00% ROI | |
STOK Stoke Therapeutics | 3/19/2025 | Reiterated Rating | $8.87 | $47.00 | Buy | $00.00 00.00% ROI | |
ZNTL Zentalis Pharmaceuticals | 3/17/2025 | Reiterated Rating | $1.77 | $10.00 | Buy | $0.00 00.00% ROI | |
STRO Sutro Biopharma | 3/17/2025 | Reiterated Rating | $8.10 | $20.00 | Neutral | $00.00 00.00% ROI | |
DYN Dyne Therapeutics | 3/17/2025 | Reiterated Rating | $12.23 | $46.00 | Buy | $00.00 00.00% ROI | |
KALV KalVista Pharmaceuticals | 3/14/2025 | Reiterated Rating | $12.25 | $20.00 | Buy | $00.00 00.00% ROI | |
ACIU AC Immune | 3/14/2025 | Reiterated Rating | $2.30 | $16.00 | Buy | $0.00 00.00% ROI | |
PRQR ProQR Therapeutics | 3/14/2025 | Boost Price Target | $1.74 | $12.00 | Buy | $0.00 00.00% ROI | |
ARVN Arvinas | 3/11/2025 | Reiterated Rating | $8.49 | $81.00 | Buy | $00.00 00.00% ROI | |
FHTX Foghorn Therapeutics | 3/7/2025 | Reiterated Rating | $4.50 | $13.00 | Buy | $0.00 00.00% ROI | |
IBRX ImmunityBio | 3/6/2025 | Initiated Coverage | $3.06 | $8.00 | Buy | $0.00 00.00% ROI | |
TARA Protara Therapeutics | 3/6/2025 | Reiterated Rating | $3.63 | $23.00 | Buy | $0.00 00.00% ROI | |
KMDA Kamada | 3/6/2025 | Reiterated Rating | $7.10 | $11.00 | Buy | $0.00 00.00% ROI | |
TCRX TScan Therapeutics | 3/6/2025 | Reiterated Rating | $1.92 | $15.00 | Buy | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 3/5/2025 | Reiterated Rating | $3.01 | $12.00 | Buy | $00.00 00.00% ROI | |
WVE WAVE Life Sciences | 3/5/2025 | Reiterated Rating | $11.23 | $22.00 | Buy | $00.00 00.00% ROI | |
MRUS Merus | 3/3/2025 | Reiterated Rating | $47.09 | $85.00 | Buy | $0.00 00.00% ROI | |
DYN Dyne Therapeutics | 2/28/2025 | Lower Price Target | $13.17 | $46.00 | Buy | $00.00 00.00% ROI | |
KYMR Kymera Therapeutics | 2/28/2025 | Boost Price Target | $29.98 | $60.00 | Buy | $00.00 00.00% ROI | |
DNLI Denali Therapeutics | 2/28/2025 | Boost Price Target | $18.60 | $87.00 | Buy | $00.00 00.00% ROI | |
CPRX Catalyst Pharmaceuticals | 2/28/2025 | Reiterated Rating | $21.83 | $35.00 | Buy | $00.00 00.00% ROI | |
KROS Keros Therapeutics | 2/27/2025 | Lower Price Target | $10.94 | $40.00 | Buy | $00.00 00.00% ROI | |
ALEC Alector | 2/27/2025 | Reiterated Rating | $1.72 | $7.00 | Buy | $0.00 00.00% ROI | |
ACAD ACADIA Pharmaceuticals | 2/27/2025 | Reiterated Rating | $18.96 | $27.00 | Buy | $00.00 00.00% ROI | |
UTHR United Therapeutics | 2/27/2025 | Reiterated Rating | $318.89 | $425.00 | Buy | $000.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 2/26/2025 | Reiterated Rating | $3.70 | $4.00 | Neutral | $0.00 00.00% ROI | |
BCRX BioCryst Pharmaceuticals | 2/25/2025 | Reiterated Rating | $8.29 | $30.00 | Buy | $0.00 00.00% ROI | |
PEPG PepGen | 2/24/2025 | Reiterated Rating | $2.81 | $16.00 | Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/21/2025 | Reiterated Rating | $116.11 | $185.00 | Buy | $000.00 00.00% ROI | |
INSM Insmed | 2/21/2025 | Reiterated Rating | $83.61 | $90.00 | Buy | $000.00 00.00% ROI | |
PRTA Prothena | 2/21/2025 | Reiterated Rating | $15.25 | $48.00 | Buy | $0.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 2/18/2025 | Reiterated Rating | $8.51 | $75.00 | Buy | $0.00 00.00% ROI | |
STOK Stoke Therapeutics | 2/18/2025 | Boost Price Target | $9.74 | $47.00 | Buy | $00.00 00.00% ROI | |
BIIB Biogen | 2/13/2025 | Lower Price Target | $133.43 | $241.00 | Buy | $000.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 2/11/2025 | Reiterated Rating | $469.97 | $550.00 | Buy | $000.00 00.00% ROI | |
PVLA Palvella Therapeutics | 2/11/2025 | Reiterated Rating | $15.72 | $38.00 | Buy | $00.00 00.00% ROI | |
CRBP Corbus Pharmaceuticals | 2/10/2025 | Reiterated Rating | $10.15 | $75.00 | Buy | $0.00 00.00% ROI | |
NBIX Neurocrine Biosciences | 2/7/2025 | Lower Price Target | $150.51 | $185.00 | Buy | $000.00 00.00% ROI | |
VRTX Vertex Pharmaceuticals | 1/31/2025 | Boost Price Target | $438.40 | $550.00 | Buy | $000.00 00.00% ROI | |
PEPG PepGen | 1/30/2025 | Lower Price Target | $1.84 | $16.00 | Buy | $0.00 00.00% ROI | |
ZNTL Zentalis Pharmaceuticals | 1/29/2025 | Lower Price Target | $1.98 | $10.00 | Buy | $0.00 00.00% ROI | |
KMDA Kamada | 1/10/2025 | Reiterated Rating | $7.32 | $11.00 | Buy | $0.00 00.00% ROI | |
PVLA Palvella Therapeutics | 1/10/2025 | Reiterated Rating | $14.25 | $38.00 | Buy | $00.00 00.00% ROI | |
CPRX Catalyst Pharmaceuticals | 1/10/2025 | Boost Price Target | $22.80 | $35.00 | Buy | $00.00 00.00% ROI | |
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date |
CGON CG Oncology | 1/10/2025 | Reiterated Rating | $30.24 | $75.00 | Buy | $00.00 00.00% ROI | |
DYN Dyne Therapeutics | 1/10/2025 | Reiterated Rating | $15.68 | $55.00 | Buy | $00.00 00.00% ROI | |
PVLA Palvella Therapeutics | 1/3/2025 | Reiterated Rating | $12.00 | $38.00 | Buy | $000.00 00.00% ROI | |
PVLA Palvella Therapeutics | 12/26/2024 | Initiated Coverage | $11.80 | $38.00 | Buy | $000.00 00.00% ROI | |
FULC Fulcrum Therapeutics | 11/14/2024 | Reiterated Rating | $3.56 | $4.00 | Neutral | $0.00 00.00% ROI | |
SYRS Syros Pharmaceuticals | 11/13/2024 | Reiterated Rating | $2.73 | $1.00 | Neutral | $0.00 00.00% ROI | |
AMLX Amylyx Pharmaceuticals | 10/18/2024 | Reiterated Rating | $3.92 | $8.00 | Buy | $00.00 00.00% ROI | |